2017 American Transplant Congress
Long-Term Follow-Up of the Safety and Effects of Bariatric Surgery on Immunosuppression in Post-Transplant Patients.
Objectives: To report the safety and feasibility of maintaining immunosuppression and graft safety after bariatric surgery among solid organ transplanted patients.Summary Background Data: Transplanted patients…2017 American Transplant Congress
Bariatric Operations at a Service of the Transplant Surgery.
IntroductionInvolvement of bariatric operations in the peri-transplant setting could be at different stages – prospective living organ donor (group 1), prospective organ recipient (2), patients…2017 American Transplant Congress
Barriers to Becoming Active on the Renal Transplant Waiting List: Have They Changed in the Last Five Years?
PURPOSEWe have previously studied the barriers preventing patients from being made active on the transplant waiting list (TWL) and implemented practice changes to improve the…2017 American Transplant Congress
Can We Successfully Overcome Obesity as a Barrier for Kidney Transplantation?
Obesity is a significant barrier for kidney transplantation (KT) with higher rates of denial for listing and longer listing to transplantation interval. We examined the…2017 American Transplant Congress
An Analysis of Tacrolimus XL Dosing in Obese Kidney Transplant Recipients.
Background:Tacrolimus extended-release (XL) is utilized in many immunosuppressive regimens post-kidney transplantation. Current dosing recommendation for the XL formulation in renal transplant (txp) is 0.15 mg/kg/day…2017 American Transplant Congress
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Dosing.
Bodyweight-based dosing of tacrolimus (Tac) is considered standard care, even though the available evidence is thin. An increasing proportion of transplant recipients is overweight, prompting…2017 American Transplant Congress
Access to Simultaneous Pancreas and Kidney Transplant (SPK) Should Not Be Restricted to BMI > 28.
SUNY Upstate Medical University, Syracuse, NY
Background: Currently, UNOS guidelines require that uremic, insulin-dependent type 1 diabetic patients have a body mass index (BMI) < 28m/kg2 in order to be eligible…2017 American Transplant Congress
Impact of Body Mass Index and Waist Circumference in Kidney Transplant Recipients.
Department of Nephrology, University Hospital of Montpellier, Montpellier, France, Metropolitan
Introduction: The impact of obesity defined by a body mass index [BMI] > 30 kg/m[sup2] on kidney allograft outcomes remains controversial. The use of BMI…2017 American Transplant Congress
Impact of Bariatric Surgery on Risk of Organ Rejection Among Solid Organ Transplant Recipients.
Medicine, Northwestern University, Chicago, IL; Surgery, Northwestern University, Chicago, IL
Background: Obesity is a common condition that contributes to organ failure. Bariatric surgery is an effective surgical therapy for obesity and has been performed both…2017 American Transplant Congress
Muscle Mass Is Predictive of Mortality in Obese Renal Transplant Patients.
Introduction: The impact of obesity (body mass index [BMI] > 30 kg/m[sup2]) on kidney allograft outcomes is controversial. Recent studies found that obesity does not…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 24
- Next Page »